These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 813755)

  • 1. The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.
    McBride WH; Tuach S; Marmion BP
    Br J Cancer; 1975 Nov; 32(5):558-67. PubMed ID: 813755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor antibodies and immunoglobulin class and subclass levels in Corynebacterium parvum-treated mice.
    James K; Willmott N; Milne I; McBride WH
    J Natl Cancer Inst; 1976 May; 56(5):1035-40. PubMed ID: 825650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active specific immunotherapy of mouse methylcholanthrene induced tumours with Corynebacterium parvum and irradiated tumour cells.
    Bomford R
    Br J Cancer; 1975 Nov; 32(5):551-7. PubMed ID: 1082344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of transplanted methylcholanthrene induced fibrosarcomata and Corynebacterium parvum on the immune response of CBA and A-HeJ mice to thymus dependent and independent antigens.
    James K; Ghaffar A; Milne I
    Br J Cancer; 1974 Jan; 29(1):11-20. PubMed ID: 4820942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of inhibition by Corynebacterium parvum of the growth of lung nodules from intravenously injected tumour cells.
    Bomford R; Olivotto M
    Int J Cancer; 1974 Aug; 14(2):226-35. PubMed ID: 4376512
    [No Abstract]   [Full Text] [Related]  

  • 7. Interaction of tumor cells and activated macrophages in vitro: modulation by Corynebacterium parvum and gold salt.
    Ghaffar A; McBride WH; Cullen RT
    J Reticuloendothel Soc; 1976 Oct; 20(4):283-9. PubMed ID: 825644
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunomodulation of chemically induced fibrosarcoma by Corynebacterium parvum.
    Gupta N; Sehgal S; Aikat BK
    Indian J Med Res; 1980 Nov; 72():688-95. PubMed ID: 7203570
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of local injection of Corynebacterium parvum on the growth of a murine fibrosarcoma.
    Woodruff MF; Dunbar N
    Br J Cancer; 1975 Jul; 32(1):34-41. PubMed ID: 1080671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprophylaxis and immunotherapy for a murine fibrosarcoma with C. granulosum and C. parvum.
    Milas L; Gutterman JU; Basic I; Hunter N; Mavligit GM; Hersh EM; Withers HR
    Int J Cancer; 1974 Oct; 14(4):493-503. PubMed ID: 4459276
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antitumor effect of lymphoid cells from Corynebacterium parvum-treated mice: effect of route of C. parvum administration.
    Ghaffar A; Cullen RT
    J Natl Cancer Inst; 1977 Mar; 58(3):717-20. PubMed ID: 300113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody responses, antitumour antibodies and Ig class and subclass levels in C. parvum treated mice.
    James K
    Dev Biol Stand; 1977 Apr 13-15; 38():173-81. PubMed ID: 608503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the Fc receptor bearing cells in a transplanted methylcholanthrene induced mouse fibrosarcoma.
    Szymaniec S; James K
    Br J Cancer; 1976 Jan; 33(1):36-50. PubMed ID: 1252329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corynebacterium parvum-induced resistance to a methylcholanthrene fibrosarcoma.
    Gupta JD; Morahan PS; Kaplan AM
    J Reticuloendothel Soc; 1978 Jan; 23(1):1-9. PubMed ID: 627989
    [No Abstract]   [Full Text] [Related]  

  • 18. Possible mechanisms in the anti-tumour activity of C. parvum.
    Cullen RT
    Dev Biol Stand; 1977 Apr 13-15; 38():265-71. PubMed ID: 305375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 20. An analysis of the factors allowing promotion (rather than inhibition) of tumour growth by Corynebacterium parvum.
    Bomford R
    Int J Cancer; 1977 May; 19(5):673-9. PubMed ID: 863546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.